SCHEMBL8375796

SCHEMBL8375796

CC(C)c1c(OCCNC(=O)OC(C)(C)C)noc1-c1ccco1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 14/20 0.43
ADORA3 P0DMS8 11/20 0.43
ADORA1 P30542 10/20 0.42
ADORA2B P29275 3/20 0.40
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
ALDH1A1 P00352 1/20 0.38
PKM P14618 1/20 0.38
SCN9A Q15858 1/20 0.37
CYP1A1 P04798 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2B6 P20813 1/20 0.37
CYP2C19 P33261 1/20 0.37
CYP3A43 Q9HB55 1/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
HPGD P15428 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8375760 0.85 IDO1 (0.43) CA12CA1CA2CA9ALDH1A1
SCHEMBL8377351 0.82 CA12 (0.40) CA12CA1CA2CA9SCN9A
SCHEMBL8375676 0.82 RAB9A (0.41) CA12CA1CA2CA9PKM
SCHEMBL8377409 0.82 PDK2 (0.41) CA12CA1CA2CA9ALDH1A1
SCHEMBL8376442 0.81 LMNA (0.40) CA12CA1CA2CA9ALDH1A1
SCHEMBL8378805 0.81 IDO1 (0.42) CA12CA1CA2CA9ALDH1A1
SCHEMBL8377390 0.78 IDO1 (0.46) CA12CA1CA2CA9ALDH1A1
SCHEMBL8377384 0.78 SCN9A (0.41) CA12CA1CA2CA9SCN9A
SCHEMBL8377356 0.78 S1PR1 (0.44) CA12CA1CA2CA9SCN9A
SCHEMBL8377410 0.77 S1PR1 (0.42) CA12CA1CA2CA9SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005116-A HAVE INHIBITION ACTIVITIES AGAINST TYPE A-MONOAMINE OXIDASE; TREATING OR PREVENTING DEPRESSION, PARKINSON'S DISEASE, ALZEHEIMER'S DEMENTIA, OR CEREBROVASCULAR DEMENTIA SANKYO COMPANY, LIMITED (JP) 1999-12-21 US disclosed
EP-0885891-A1 ISOXAZOLE DERIVATIVES SANKYO COMPANY LIMITED (JP) 1998-12-23 EP disclosed